(Fighting New Coronary Pneumonia) Russia is expected to start providing vaccines produced outside Russia to foreign markets in November

  China News Agency, Moscow, September 4 (Reporter Wang Xiujun) Dmitriev, President of the Russian Direct Investment Fund (cooperative vaccine producer), said at an online press conference held on the 4th that he hopes to report to Foreign markets provide vaccines produced outside Russia.

  On August 11, Russian President Vladimir Putin announced that Russia has registered the world's first new coronavirus vaccine "Satellite-V".

The vaccine was developed by the National Research Center for Epidemiology and Microbiology of Gamaliel, and is a human adenovirus vector vaccine.

According to the "Russia 24" TV station quoted on September 4, Deputy Director of the Gamallea National Research Center for Epidemiology and Microbiology, Logunov, the "Satellite-V" new coronavirus vaccine has begun large-scale production.

  Dmitriev said that 40 countries, including Brazil, Egypt, India, Uzbekistan, Mexico, and Argentina, are currently interested in purchasing the Russian new crown virus vaccine.

But Russia's vaccine production capacity can only meet the domestic market at first.

  Dmitriev said that the Russian Direct Investment Fund is negotiating with other countries to export the new coronavirus vaccine.

At present, Russia has reached an agreement with India that India will produce 300 million Russian new crown virus vaccines every year.

  On the same day, Dmitriev also revealed that the data from the first and second phases of the new coronavirus has been sent to the Philippine Ministry of Health.

They are studying.

We hope to start clinical trials of the new coronavirus vaccine in the Philippines in September.

In addition, a clinical trial of the new coronavirus vaccine is expected in Saudi Arabia in September.

  According to the Russian Satellite News Agency, Russian Defense Minister Shoigu and Moscow Mayor Sobyanin both announced that they had been vaccinated against the new coronavirus.

  The "Satellite-V" new coronavirus vaccine has not yet completed the third phase of clinical trials.

According to the website of the Russian Ministry of Health on the 3rd, the third phase of the vaccine will be completed before December 31, 2022.

(Finish)